ENHANCED ANTI-TUMOR ACTIVITY OF CD19.CAR-NK CELLS BY INCORPORATING IL-27 AFB Biggi; RN Silvestre; JTC Azevedo; MC Tirapelle; KCR Malmegrim; ML Figueiredo; DT Covas; V Picanço-Castro;

PROMOTER CHOICE: THE IDEAL PROMOTER TO DRIVE CHIMERIC ANTIGEN RECEPTOR (CAR) EXPRESSION IN NK CELLS RN Silvestre; J Eitler; JTC Azevedo; KCR Malmegrim; K Swiech; DT Covas; T Tonn; V Picanço-Castro;

ANTI-CD19 CARS ARMED WITH NK RECEPTOR-DERIVED ACTIVATION DOMAINS DEMONSTRATE TO IMPROVE CAR-NK ANTITUMOR EFFECTOR FUNCTION AND ARE DIFFERENTIALLY ENHANCED BY DASATINIB MHD Santos; JTC Azevedo; RN Silvestre; RDT Calado; DT Covas; V Picanç-Castro;